Statistics for Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country

Total visits

views
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country 0

Total visits per month

views
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0

File Visits

views
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.pdf 3